United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$44Mraised across 3 rounds since 2017, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
From Cybrexa Therapeutics's own website: 7 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Connecticut Innovations
Advantage CapitalCT Innovations
HighCape PartnersCycle Venture PartnersHighCape Capital Special Opportunities FundMissing a round, or an investor who was in one? Tell us.
Cybrexa Therapeutics's investors include Connecticut Innovations, Advantage Capital, CT Innovations, HighCape Partners and Cycle Venture Partners, and 1 more on record.
Cybrexa Therapeutics has raised $44M across 3 rounds since 2017.
Cybrexa Therapeutics's most recent round was a Series B of $25M in Mar 2021.
Its most recent round, $25M in Mar 2021, is also its largest on record.
Cybrexa Therapeutics's first round on record, in Jun 2017, was backed by Connecticut Innovations and HighCape Partners.
Cybrexa Therapeutics's latest named round is a Series B, in Mar 2021.
Cybrexa Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
